| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 682996 | Null | 0.035202825328704 | 0.078538374 |
| NSC 685285 | Null | 0.035202825328704 | 0.20049257 |
| NSC 693037 | Null | 0.035202825328704 | 0.25277362 |
| NSC 699934 | Null | 0.035202825328704 | -0.13790482 |
| NSC 718564 | Null | 0.0352028253287042 | -0.056867764 |
| NSC 726578 | Null | 0.0352028253287042 | -0.25379775 |
| NSC 743433 | 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one | 0.0352028253287042 | 0.021195738 |
| NSC 751605 | (E)-N-[4-(1-benzoylpiperidine-4-yl)butyl]-3-(pyridin-3-yl)acrylamide | 0.0352028253287042 | 0.076466205 |
| NSC 752278 | 2,7-Bis-[2-(2,3,4-trimethoxy-benzylamino)-ethyl]-benzo[lmn][3,8]phenanthroline-1,3,6,8-tetraone di-p-toluensulfonate salt | 0.0352028253287042 | 0.21353081 |
| NSC 753377 | 3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine | 0.0352028253287042 | 0.077302869 |